Polar Capital Holdings’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
745,000
-80,000
| -10% | -$1.2M | 0.06% | 180 |
|
|
2025
Q1 | $13.3M | Buy |
825,000
+75,000
| +10% | +$1.21M | 0.08% | 175 |
|
|
2024
Q4 | $17.5M | Buy |
750,000
+250,000
| +50% | +$5.82M | 0.1% | 154 |
|
|
2024
Q3 | $14.7M | Hold |
500,000
| – | – | 0.07% | 169 |
|
|
2024
Q2 | $11.8M | Hold |
500,000
| – | – | 0.07% | 170 |
|
|
2024
Q1 | $19M | Hold |
500,000
| – | – | 0.1% | 150 |
|
|
2023
Q4 | $10.8M | Buy |
500,000
+200,000
| +67% | +$4.3M | 0.07% | 190 |
|
|
2023
Q3 | $3.68M | Buy |
+300,000
| New | +$3.68M | 0.03% | 237 |
|